Xilio Therapeutics, Inc.XLONASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank83
Studio
Year-over-Year Change

Return on equity

Latest
0.00%
↓ 100% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
48.15%
Historical baseline
PeriodValueYoY Change
20250.00%+100.0%
2024-330.95%-59.5%
2023-207.47%-148.4%
2022-83.51%-104.3%
2021-40.88%-103.9%
20201044.82%+2424.3%
2019-44.95%-